Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

310 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe Impairment of T-cell Immunity and Pulmonary GvHD Are Major Risk Factors for Nontuberculous Mycobacterial Infection After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.
Ascunce M, Coccolo A, Mozo Y, Baquero-Artigao F, Rodriguez-Molino P, Toro-Rueda C, García-Clemente P, Sánchez-Zapardiel E, López-Granados E, Corral-Sánchez D, Bueno D, Sisinni L, Pérez-Martínez A, Calvo C, Del Rosal T. Ascunce M, et al. Among authors: bueno d. Pediatr Infect Dis J. 2024 Sep 1;43(9):885-888. doi: 10.1097/INF.0000000000004380. Epub 2024 May 7. Pediatr Infect Dis J. 2024. PMID: 38713829
Younger age and induction failure predict outcomes in infant leukemia: 30 years of experience in a tertiary center.
Ochoa-Fernández B, Galán-Gómez V, Guerra-García P, Sanromán S, Martínez I, Bueno D, Mozo Y, Sisinni L, Losantos I, González B, Pérez-Martínez A. Ochoa-Fernández B, et al. Among authors: bueno d. Front Pediatr. 2023 May 30;11:1166176. doi: 10.3389/fped.2023.1166176. eCollection 2023. Front Pediatr. 2023. PMID: 37325355 Free PMC article.
Treosulfan-Based Conditioning Regimen In Pediatric Hematopoietic Stem Cell Transplantation: A Retrospective Analysis on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Galán V, Beléndez C, Echecopar C, Estival P, Sissini L, Olivas R, Bueno D, Molina B, Fuentes C, Regueiro A, Benítez I, Plaza M, Margarit A, Rifón J, Pascual A, Palomo P, Urtasun A, Fuster JL, Díaz de Heredia C, Fernández Navarro JM, González-Vicent M, Ruz B, Pérez-Martínez A. Galán V, et al. Among authors: bueno d. Transplant Cell Ther. 2023 Nov;29(11):702.e1-702.e11. doi: 10.1016/j.jtct.2023.08.016. Epub 2023 Aug 16. Transplant Cell Ther. 2023. PMID: 37595686 Free article.
Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC).
Benítez Carabante MI, Bueno D, Alonso García L, López Torija I, Marsal J, Fernandez Navarro JM, Uria Oficialdegui ML, Panesso M, Molina B, Beléndez Bieler C, Palomo P, Pérez Martínez A, Diaz-de-Heredia C. Benítez Carabante MI, et al. Among authors: bueno d. Transplant Cell Ther. 2024 Jun;30(6):601.e1-601.e13. doi: 10.1016/j.jtct.2024.03.019. Epub 2024 Mar 21. Transplant Cell Ther. 2024. PMID: 38521410
Haploidentical versus Cord Blood Transplantation in Pediatric AML. A Retrospective Outcome Analysis on Behalf of the Pediatric Subcommittee of GETH (Grupo Español de Trasplante Hematopoyético).
Sisinni L, Monserrate GXA, Hurtado JMP, Panesso M, Molina B, Fuentes C, Fuster JL, Verdu-Amoros J, Regueiro A, Palomo P, Beléndez C, Pascual A, Badell I, Mozo Y, Bueno D, Pérez-Martínez A, Fernández JM, Vicent MG, de Heredia CD. Sisinni L, et al. Among authors: bueno d. Transplant Cell Ther. 2024 Oct;30(10):1015.e1-1015.e13. doi: 10.1016/j.jtct.2024.07.013. Epub 2024 Jul 25. Transplant Cell Ther. 2024. PMID: 39067788
Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood. A study of the Spanish Pediatric Group for Hematopoietic Cell Transplantation and Cell Therapy (GETH-TC).
Uria-Oficialdegui ML, Quintero V, Benitez-Carabante MI, Bueno D, Trabazo M, Lopez-Duarte M, Alonso L, Panesso M, Murillo-Sanjuan L, Fuentes C, Gomez G, Gonzalez-Vicent M, Verdu J, Diaz-de-Heredia C. Uria-Oficialdegui ML, et al. Among authors: bueno d. Bone Marrow Transplant. 2024 Dec;59(12):1773-1776. doi: 10.1038/s41409-024-02406-z. Epub 2024 Sep 3. Bone Marrow Transplant. 2024. PMID: 39227649 No abstract available.
Post-transplant relapse in pediatric acute lymphoblastic leukemia in the era of CAR-T cell therapy. A multicenter analysis of Grupo Español de Trasplante Hematopoyetico y Terapia Celular (GETH-TC) Pediatric Committee.
González Vicent M, Molina B, Panesso M, Bueno D, Pascual A, Vinagre S, Mozo Y, Fuster JL, Olivas R, Fuentes C, López M, Regueiro A, Palomo P, Díaz de Heredia C. González Vicent M, et al. Among authors: bueno d. Cytotherapy. 2024 Dec 2:S1465-3249(24)00942-3. doi: 10.1016/j.jcyt.2024.11.016. Online ahead of print. Cytotherapy. 2024. PMID: 39708044
310 results